









Markets
/
Stocks
/
nasdaq-veev
/

Veeva Systems Inc

VEEV

183.650USD

-0.200-0.11%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

30.18BMarket Cap

34.87P/E TTM



Veeva Systems Inc

183.650

-0.200-0.11%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Veeva Systems Inc

Currency: USD Updated: 2026-02-06

Key Insights

Veeva Systems Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 49 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 306.57.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Veeva Systems Inc's Score

Industry at a Glance

Industry Ranking

49 / 205

Overall Ranking

141 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Veeva Systems Inc Highlights

StrengthsRisks

Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. It offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and the strategic business functions from research and development (R&D) through commercialization. Its four product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes, and partners across content management, training, quality management, assurance, and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Veeva Data Cloud is a data platform comprised of connected reference data, deep data, and transaction data.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 27.45% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 2.75B.

Undervalued

The company’s latest PE is 34.87, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 146.75M shares, decreasing 4.51% quarter-over-quarter.

Held by Baillie Gifford

Star Investor Baillie Gifford holds 49.00 shares of this stock.

Analyst Rating

Based on 33 analysts

Buy

Current Rating

306.574

Target Price

+66.75%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Veeva Systems Inc is 8.83, ranking 30 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 811.24M, representing a year-over-year increase of 16.02%, while its net profit experienced a year-over-year increase of 27.12%.

Score

Industry at a Glance

Previous score

8.83

Change



Financials

9.48

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.80

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

9.33

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.53

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Veeva Systems Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Veeva Systems Inc is 6.40, ranking 162 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 34.87, which is 114.60% below the recent high of 74.84 and 0.00% above the recent low of 34.87.

Score

Industry at a Glance

Previous score

6.40

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 49/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Veeva Systems Inc is 7.82, ranking 110 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 320.00, with a high of 380.00 and a low of 222.00.

Score

Industry at a Glance

Previous score

7.82

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 33 analysts

Buy

Current Rating

306.574

Target Price

+66.75%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Veeva Systems Inc

VEEV

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Thermo Fisher Scientific Inc

TMO

Danaher Corp

DHR

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Veeva Systems Inc is 6.74, ranking 96 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 226.80 and the support level at 159.19, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.60

Change

0.14

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-6.723

Sell

RSI(14)

21.586

Sell

STOCH(KDJ)(9,3,3)

9.843

Oversold

ATR(14)

8.025

Low Volatility

CCI(14)

-135.352

Sell

Williams %R

88.341

Oversold

TRIX(12,20)

-0.599

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

190.468

Sell

MA10

202.628

Sell

MA20

213.569

Sell

MA50

223.475

Sell

MA100

255.174

Sell

MA200

262.662

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Veeva Systems Inc is 7.00, ranking 80 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 89.27%, representing a quarter-over-quarter increase of 0.54%. The largest institutional shareholder is The Vanguard, holding a total of 15.30M shares, representing 9.30% of shares outstanding, with 3.48% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

15.36M

+3.06%

Gassner (Peter P)

12.27M

BlackRock Institutional Trust Company, N.A.

6.87M

+0.98%

AllianceBernstein L.P.

5.94M

+4.14%

Fidelity Management & Research Company LLC

5.93M

+15.07%

T. Rowe Price Investment Management, Inc.

3.90M

-11.90%

Principal Global Investors (Equity)

3.85M

+11.25%

State Street Investment Management (US)

3.50M

+2.23%

Geode Capital Management, L.L.C.

3.15M

+1.85%

The Linonia Partnership LP

2.97M

+43.42%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Veeva Systems Inc is 7.27, ranking 44 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.09. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.